Evidence map›Paper›PMID 40666130›Full record

ArticleBioinformatics advances2025

Survey and improvement strategies for gene prioritization with large language models.

Matthew B Neeley, Guantong Qi, Guanchu Wang, Ruixiang Tang, Dongxue Mao, Chaozhong Liu, Sasidhar Pasupuleti, Bo Yuan, Fan Xia, Pengfei Liu and 2 more

Abstract read
In one paragraph

Article in Bioinformatics advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Matthew B NeeleyJan and Dan Duncan Neurological Research Institute at Texas Children's Hospital, Houston, TX, 77030, United States.
Guantong QiJan and Dan Duncan Neurological Research Institute at Texas Children's Hospital, Houston, TX, 77030, United States.
Guanchu WangDepartment of Computer Science, Rice University, Houston, TX, 77005, United States.
Ruixiang TangDepartment of Computer Science, Rutgers University, New Brunswick, NJ, 08854, United States.
Dongxue MaoJan and Dan Duncan Neurological Research Institute at Texas Children's Hospital, Houston, TX, 77030, United States.
Chaozhong LiuJan and Dan Duncan Neurological Research Institute at Texas Children's Hospital, Houston, TX, 77030, United States.
Sasidhar PasupuletiJan and Dan Duncan Neurological Research Institute at Texas Children's Hospital, Houston, TX, 77030, United States.
Bo YuanDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, 77030, United States.
Fan XiaDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, 77030, United States.
Pengfei LiuDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, 77030, United States.
Zhandong LiuJan and Dan Duncan Neurological Research Institute at Texas Children's Hospital, Houston, TX, 77030, United States.ORCID https://orcid.org/0000-0002-7608-0831
Xia HuDepartment of Computer Science, Rice University, Houston, TX, 77005, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Motivation: Rare diseases remain difficult to diagnose due to limited patient data and genetic diversity, with many cases remaining undiagnosed despite advances in variant prioritization tools. While large language models have shown promise in medical applications, their optimal application for trustworthy and accurate gene prioritization downstream of modern prioritization tools has not been systematically evaluated. Results: We benchmarked various language models for gene prioritization using multi-agent and Human Phenotype Ontology classification approaches to categorize patient cases by phenotype-based solvability levels. To address language model limitations in ranking large gene sets, we implemented a divide-and-conquer strategy with mini-batching and token limiting for improved efficiency. GPT-4 outperformed other language models across all patient datasets, demonstrating superior accuracy in ranking causal genes. Multi-agent and Human Phenotype Ontology classification approaches effectively distinguished between confidently-solved and challenging cases. However, we observed bias toward well-studied genes and input order sensitivity as notable language model limitations. Our divide-and-conquer strategy enhanced accuracy, overcoming positional and gene frequency biases in literature. This framework optimized the overall process for identifying disease-causal genes compared to baseline evaluation, better enabling targeted diagnostic and therapeutic interventions and streamlining diagnosis of rare genetic disorders. Availability and implementation: Software and additional material is available at: https://github.com/LiuzLab/GPT-Diagnosis.

Identifiers

PMID40666130
PMCPMC12263109

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.